Facebook
Twitter
LinkedIn
Forward2016 VAM: 2101 - Immunoglobulin E: The First 50 Years and Beyond
IgE is a central molecule involved in pathogenesis of allergic disease. Its discovery was a major landmark in facilitating the research into mechanisms of allergy as well as diagnosing and treating allergic disease. This session will first review the history of the discovery of IgE. It will then be followed by what we currently know and do not know about its biology and diagnostic utility. Finally, existing and emerging therapies targeting IgE in various allergic and immunologic disorders will be reviewed.
AMA PRA Category 1 Credits™: 1.50
CE: 1.50
Credit must be claimed by May 31, 2018. Any credit request on or after June 1, 2018 will be subject to an administrative fee.
Target Audience
Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals
Learning Objectives
1. Describe the historic aspects and key scientists involved in discovery of IgE
2. Discuss the role of IgE in pathogenesis and diagnosis of allergic disease, and mechanisms of its regulation of production
3. Identify the disorders that can be successfully treated by targeting allergen specific IgE
Additional Information
| Attachment | Size |
|---|---|
 2016 Annual Meeting Disclosures | 120.13 KB |
Prof. Thomas B. Casale, MD FAAAAI, University of South Florida Morsani College of Medicine, Tampa, FL
Relevant relationships: Advisory Board: Novartis, Genentech
Prof. Hannah J. Gould, PhD, King's College London, United Kingdom
Relevant relationships: None
Prof. Thomas A.E. Platts-Mills, MD PhD FAAAAI, University of Virginia Health System, Charlottesville, VA
Relevant relationships: Research support (Ongoing): Phadia/Thermo Fisher
Annual Meeting sessions and faculty were reviewed by members of the Practice Improvement Subcommittee. Disclosures are located in the 2016 Annual Meeting Disclosures PDF.
Available Credit
- 1.50 AttendanceAttendance credit.
- 1.50 CECE credit.
- 1.50 CMECME credit.